References
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J. Clin 2020;70:7–30.
- https://www.who.int/health-topics/cancer#tab=tab_3 (Last access 10/10/2021).
- https://gco.iarc.fr/today/home (Last access 10/10/2021).
- Cazzamalli S, Dal Corso A, Widmayer F, Neri D. Chemically defined antibody- and small molecule-drug conjugates for in vivo tumor targeting applications: a comparative analysis. J Am Chem Soc 2018;140:1617–21.
- do Pazo C, Nawaz K, Webster RM. The oncology market for antibody-drug conjugates. Nat Rev Drug Discov 2021; 20:583–4.
- Pysz I, Jackson PJM, Thurston DE, Introduction to antibody–drug conjugates (ADCs), In Cytotoxic Payloads for Antibody–Drug Conjugates, 2019, 1–30.
- Peters C, Brow S. Antibody–drug conjugates as novel anti-cancer chemotherapeutics. Biosci Rep 2015;4:e00225.
- Dal Corso A, Gébleux R, Murer P, et al. A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo. J Control Release 2017; 264:211–8.
- Quintieri L, Geroni C, Fantin M, et al. Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes. Clin Cancer Res 2005; 11:1608–17.
- Lv P-C, Putt KS, Low PS. Low Evaluation of nonpeptidic ligand conjugates for SPECT imaging of hypoxic and carbonic anhydrase IX-expressing cancers. Bioconjug Chem 2016;27:1762–9.
- Krall N, Pretto F, Mattarella M, et al. A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo. J Nucl Med 2016;57:943–9.
- Le Chevalier-Isaad A, Papini AM, Chorev M, Rovero P. Side chain-to-side chain cyclization by click reaction. J Pept Sci 2009;15:451–4.
- Testa C, Scrima M, Grimaldi M, et al. 1,4-Disubstituted-[1,2,3]triazolyl-containing analogs of MTII – design, synthesis, conformational analysis, and biological activity. J Med Chem 2014;57:9424–34.
- Battke C, Kremmer E, Mysliwietz J, et al. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol Immunother 2011;60:649–58.
- Carta F, Vullo D, Osman SM, et al. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. Bioorg Med Chem 2017;25:2569–76.
- Vullo D, Durante M, Di Leva FS, et al. Monothiocarbamates strongly inhibit carbonic anhydrases in vitro and possess intraocular pressure lowering activity in an animal model of glaucoma. J Med Chem 2016;59:5857–67.
- Ratto F, Witort E, Tatini F, et al. Plasmonic particles that hit hypoxic cells. Adv Funct Mater 2015;25:316–23.
- Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.